U.S. market Closed. Opens in 6 hours 4 minutes

DTIL | Precision BioSciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue48.73M25.10M115.53M24.29M22.24M10.88M6.48M
Cost of Revenue8.26M9.00MN/AN/AN/AN/AN/A
Gross Profit40.47M16.09M115.53M24.29M22.24M10.88MN/A
Operating Expenses84.21M125.46M154.93M134.11M109.44M58.80M28.34M
Selling, General & Admin34.85M41.52M39.69M36.05M27.03M13.67M8.02M
Research & Development49.35M83.94M115.24M98.06M82.42M45.12M20.32M
Other Operating ExpensesN/AN/AN/AN/A-9.76MN/AN/A
Operating Income-43.74M-100.37M-39.40M-109.83M-87.20M-47.91M-21.97M
Other Expenses / Income1.21M-11.27M8.80M822.00K-5.67M1.88M872.00K
Before Tax Income-42.53M-111.64M-30.60M-109.01M-92.88M-46.04M-21.10M
Income Tax Expenses27.24M11.27M316.00K10.43M-9.58M1.88MN/A
Net Income-69.77M-122.91M-30.92M-109.01M-83.30M-46.04M-21.10M
Interest Expenses2.23M1.11M132.00KN/A182.00KN/AN/A
Basic Shares Outstanding3.84M2.93M1.96M1.73M1.40M49.03M33.65M
Diluted Shares Outstanding3.84M2.93M1.96M1.73M1.40M49.03M33.65M
EBITDA-35.48M-98.47M-28.81M-99.19M-87.38M-45.56M-19.67M
EBITDA Margin-72.82%-392.35%-24.94%-408.45%-392.92%-418.62%-303.32%
EBIT-40.30M-110.53M-30.47M-98.58M-92.69M-44.16M-21.10M
EBIT Margin-82.70%-440.38%-26.37%-405.92%-416.83%-405.79%-325.45%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙